
NVM supports £3.5m CBio merger
NVM Private Equity has invested £3.5m in portfolio company Cleveland Biotech’s (CBio) merger with Biological Preparations (BP).
Following the deal, the combined entity aims to be the market leader in biological solutions for commercial cleaning and food, oil and grease management. The enlerged group will employ 27 people.
Previous funding
NVM initially invested £3m to support CBio's £4.4m MBO in June 2013.
Company
Cardiff-based BP was established in 2008 and focuses on the development of biotechnology services for the food and drink, water treatment, agricultural and cleaning services markets. The company creates its products using microbial, enzyme, plant extract, organic acid and biocide technology – all of which are supplied from its own facility in Caerphilly, Wales.
The company employs 10 people.
Based in Stockton-on-Tees, CBio initially provided nitrifying bacteria to water treatment plants when it was first established in 1992. Today, the company develops fermented bacteria for use in a range of biological products, which naturally erode organic pollutants including grease, fat, oil, diesel, uric acid and limescale. CBio targets food, oil and grease management and typical customers include supermarkets, restaurants, hotels, pubs and local authorities.
People
James Patterson is managing director of BP. Ben Hoskyns is managing director of CBio. Mauro Biagioni is partner of NVM.
Advisers
Equity – Aon, John Donald (Insurance); BDO, Graham Elsworth, David Billington (Financial due diligence, tax); Bond Dickinson, Jamie Pass (Legal); Continuum, Steve Wycherley (Management due diligence); Springboard Corporate Finance, David Neate (Corporate finance); Fairgrove Partners, Paddy Woods Ballard (Commercial due diligence); Square One Law, Mark Lazenby (Legal).
Company – Berry Smith, Andrew Bond (Legal)
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater